Clinical trial
Hydroxychloroquine in Cystic Fibrosis
NCT00311883 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00311883 |
|---|---|
| Title | Hydroxychloroquine in Cystic Fibrosis |
| Official title | Phase 1 Study of Hydroxychloroquine in Cystic Fibrosis |
| Lead sponsor | Vanderbilt University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | hydroxychloroquine |
| Enrollment | 20 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 6, 2006 |
| Last update posted | Jan 30, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: